Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

HYTN Innovations Inc C.HYTN

HYTN Innovations Inc. is a Canada-based company that creates products containing psychoactive and psychotropic compounds, including cannabinoids derived from cannabis. The Company formulates, manufactures, markets, and sells cannabis goods. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. All its sparkling cannabis beverages contain 10 milligrams (mg) of THC and are made using its process, Elevation Technology. Its products include Rosewater Lemonade, Watermelon Mint, Lemongrass Ginger, and Blood Orange. Its Rosewater Lemonade is a sugar-free exploration of citrus accented with floral notes. Blood Orange is formulated to bring out the sweet flavors found in this seasonal citrus fruit. Its activities are focused on a single production and manufacturing facility, based in Kelowna, British Columbia. The Company’s subsidiaries include HYTN Innovations Inc., HYTN Beverage Corp, HYTN Cannabis Inc., and 1306562 B.C. Ltd.


CSE:HYTN - Post by User

Post by Betteryear2on Mar 21, 2024 10:02am
43 Views
Post# 35944751

HYTN Secures GMP Certification

HYTN Secures GMP CertificationVANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN "HYTN or The Company"), a Canadian company at the forefront of developing, formulating, and manufacturing products with psychoactive and psychotropic compounds, including those from cannabis and psilocybin, has been awarded Good Manufacturing Practice (GMP) certification by Australia's Therapeutic Goods Administration (TGA) for its Kelowna production facility. This announcement supplements the company’s March 3rd, 2024, release announcing that it had successfully completed the GMP Audit.

HYTN Secures GMP Certification (globenewswire.com)
<< Previous
Bullboard Posts
Next >>